Urotensin-II in systemic sclerosis: A new peptide in pathogenesis

Clinical Rheumatology

Volumn 30, Issue 6, 2011, Pages 837-842

  Pehlivan, Yavuz ^a   Onat, Ahmet Mesut ^a   Comez, Gazi ^a   Babacan, Taner ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Endothelin 1; Systemic sclerosis; Urotensin II

Indexed keywords

AUTOANTIBODY; ENDOTHELIN 1; UROTENSIN II;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOREACTIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC SCLEROSIS;

CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; UROTENSINS;

EID: 79959619240     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1688-3     Document Type: Article

References (41)

1. Vancheeswaran R, Magoulas T, Efrat G et al (1994) Circulating endothelin-1 levels in systemic sclerosis subsets: a marker of fibrosis or vascular dysfunction? J Rheumatol 21:1838-1844
2. Abraham DJ, Vancheeswaran R, Dashwood MR et al (1997) Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol 151:831-841 (Pubitemid 27385615)
3. Rubin LJ, Badesch DB, Brast RJ et al (2002) Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896-903 (Pubitemid 34984638)
4. Denton CP, Humbert M, Rubin L et al (2006) Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis 65:1336-1340 (Pubitemid 44620443)
5. Maguire JJ, Kuc RE, Davenport AP (2000) Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131:441-1446
6. Zhu YC, Zhu YZ, Moore PK (2006) The role of urotensin II in cardiovascular and renal physiology and diseases. Br J Pharmacol 148:884-901
7. Zhang YM, Liu WJ, Shi YZ et al (2008) Expressions of urotensin II and its receptor in pulmonary arteries in rats with chronic thromboembolic pulmonary hypertension. Zhonghua Jie He He Hu Xi Za Zhi 31:37-41
8. Richards AM, Nicholls MG, Lainchbury JG et al (2002) Plasma urotensin II in heart failure. Lancet 17(360):545-546 (Pubitemid 35232110)
9. Totsune K, Takahashi K, Arihara Z et al (2003) Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci (Lond) 104:1-5 (Pubitemid 36249917)
10. Totsune K, Takahashi K, Arihara Z et al (2001) Role of urotensin II in patients on dialysis. Lancet 8(358):810-811 (Pubitemid 32868735)
11. Masi AT, Medsger TA, Rodnan GP et al (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581-590 (Pubitemid 10101764)
12. Clements P, Lachenbruch P, Seibold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281-1285
13. Valentini G, Della Rossa A, Bombardieri S et al (2001) European multicentre study to define disease activity criteria for systemic syclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592-598
14. Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159-2167 (Pubitemid 29487010)
15. Silman A, Akesson A, Newman J (1998) Assessment of functional ability in patients with SSc: a proposed new disability assessment instrument. J Rheumatol 25:79-83 (Pubitemid 28060122)
16. Ozer O, Davutoglu V, Ercaan S et al (2009) Plasma urotensin II as a marker for severity of rheumatic valve disease. Tohoku J Exp Med 218:57-62
17. Pache M, Schwarz HA, Kaiser HJ et al (2002) Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit 8:616-619
18. Julkunen H, Saijonmaa O, Gronhagen-Riska et al (1991) Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus. Ann Rheum Dis 50:526-527
19. Yoshio T, Masuyama J, Mimori A et al (1995) Endothelin-1 release from cultured endothelin cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis 54:361-365
20. Stewart DJ, Levy RD, Cernacek P et al (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114:464-469
21. Peterlana D, Puccetti A, Caramaschi P et al (2006) Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis. Scand J Rheumatol 35:133-137
22. Yamane K, Miyauchi T, Suzuki N et al (1992) Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol 19:1566-1571
23. Shi-Wen X, Chen Y, Denton CP et al (2004) Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15:2707-2719 (Pubitemid 38691860)
24. Abraham D, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9 Suppl 2:S2
25. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S (2005) Soluble adhesion molecules (SVCAM-1, sE-selectin), vascular endothelial growth factor(VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 24:111-116 (Pubitemid 40552961)
26. Morelli S, Ferri C, Polettini E et al (1995) Plasma endothelin-1 levels, pulmoner hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med 99:255-260
27. Yamane K, Kashiwagi H, Suzuki N et al (1991) Elevated plasma levels of endothelin-1 in systemic sclerosis. Arthritis Rheum 34:243-244
28. Bern HA, Pearson D, Larson BA et al (1985) Neurohormones from fish tails: the caudal neurosecretory system. I. Urophysiology and caudal neurosecretory system in fishes. Recent Prog Horm Res 41:533-552
29. Douglas SA, Tayara L, Ohlstein EH et al (2002) Congestive heart failure and expression of myocardial urotensin-II. Lancet 359:1990-1997 (Pubitemid 34663713)
30. Lapp H, Boerrigter G, Costello-Boerrigter LC et al (2004) Elevated plasma urotensin-II-like immunoreactivity in ischemic cardiomyopathy. Int J Cardiol 94:93-97 (Pubitemid 38314694)
31. Joyal D, Huynh T, Aiyar N et al (2006) Urotensin II levels in acute coronary syndromes. Int J Cardiol 108:31-35 (Pubitemid 43324903)
32. Lim M, Honisett S, Sparkes CD, Komesaroff P, Kompa A, Krum H et al (2004) Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure. Circulation 109:1212-1214 (Pubitemid 38372777)
33. Sondermeijer B, Kompa A, Komesaroff P et al (2005) Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension. Am J Hypertens 18:1195-1199 (Pubitemid 41337972)
34. Kompa AR, Thomas WG, See F et al (2004) Cardiovascular role of urotensin II: effect of chronic infusion in the rat. Peptides 25:1783-1788 (Pubitemid 39346221)
35. Tran L, Kompa AR, Kemp PA et al (2010) Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats. Am J PAHysiol Heart Circ PAHysiol 298:608-613
36. Qi J, Du J, Tang X et al (2004) The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart Vessels 19:81-88 (Pubitemid 38489035)
37. Djordjevic T, Görlach A (2007) Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension? Thromb Haemost 98:952-962
38. Djordjevic T, BelAiba RS, Bonello S et al (2005) Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25:519-525 (Pubitemid 40315672)
39. Zhang Y, Li J, Cao J et al (2002) Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium. Heart Vessels 16:64-68 (Pubitemid 34110716)
40. Cheung BM, Leung R, Man Yet al (2004) Plazma concentration of urotensin II is raised in hypertension. J Hypertens 22:1341-1344
41. Khan SQ, Bhandari SS, Quinn P et al (2007) Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans. Int J Cardiol 117:323-328 (Pubitemid 46507623)